arrow
B

Bruna Bellaver

university of pittsburgh
H指数:31
被引数:3,203

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EXPRESS: Longitudinal FDG-PET reveals early hypermetabolism associated with astrocyte changes in TgF344-AD rats

EXPRESS:纵向FDG-PET揭示TgF344-AD大鼠中与星形胶质细胞变化相关的早期高代谢

2026-10-280
PRE
Attention‐deficit/hyperactivity disorder polygenic risk score and incidence of cognitive impairment in older adults: A prospective multicohort study

注意缺陷/多动障碍多基因风险评分与老年人认知障碍发生风险:一项前瞻性多队列研究

2026-10-150
OA
Tau-PET correlates of mild behavioral impairment in preclinical and prodromal Alzheimer's disease: A head-to-head comparison of Flortaucipir and MK6240

帕金森行为障碍在临床前和前驱期阿尔茨海默病中的Tau-PET相关性:Flortaucipir与MK6240的头对头比较

2026-09-290
OAAI
Microglia as a key player in Aβ‐related astrocyte reactivity

小胶质细胞作为Aβ相关星形胶质细胞反应性的关键参与者

2025-12-250
OAAI
Capacity building in dementia research: insights from the World Young Leaders in Dementia
2025-12-170
OAAI
In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer’s disease continuum

体内测量的路易体病理与阿尔茨海默病连续谱系中的神经精神症状相关

2025-12-140
PRE
Impact of cardiometabolic factors and AD plasma biomarkers on white matter hyperintensities volume in individuals with cognitive complaints from the global south

来自全球南方认知主诉个体的心代谢因素及AD血浆生物标志物对白质高信号体积的影响

2025-12-100
PRE
APOE ε4 potentiates tau related reactive astrogliosis assessed by cerebrospinal fluid YKL40 in Alzheimer’s disease

APOE ε4 增强阿尔茨海默病中与tau蛋白相关的反应性星形胶质细胞增生,该增生通过脑脊液YKL40进行评估。

2025-11-200
OA
Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease

小胶质细胞调节阿尔茨海默病中Aβ依赖性的星形胶质细胞反应性

2025-11-060
OAAI
Association between the genetic risk for attention-deficit/hyperactivity disorder and cognitive function in older age: The MYHAT population-based study

注意缺陷多动障碍的遗传风险与老年认知功能的关系:MYHAT人群为基础的研究

2025-10-220
OAAI
Amyloid beta and tau are associated with the dual effect of neuroinflammation on neurodegeneration

A Amyloid beta和tau与神经炎症对神经退行性病变的双效作用相关。Alzheimers. Dement. 21:e70746

2025-09-292
OAAI
Diagnostic performance of Alzheimer’s disease blood and CSF biomarkers in a Brazilian cohort with low educational attainment

阿尔茨海默病血液和脑脊液生物标志物在巴西低教育程度队列中的诊断性能

2025-09-080
PRE
Association between FDG- and TSPO-PET signals across human and animal studies investigating neurodegenerative conditions: a systematic review

FDG-和TSPO-PET信号在研究神经退行性疾病的跨人类和动物研究中的关联:一项系统综述

2025-09-040
PRE
CSF total tau as a proxy of synaptic degeneration

脑脊液总tau蛋白作为突触退行性变的替代指标

2025-08-290
OAAI
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease

Rohden, F, Ferreira, PCL, Bellaver, B, Ferrari-Souza, JP, Aguzzoli, CS, Soares, C, et al. 胶质细胞反应性与老化及阿尔茨海默病中的突触功能障碍相关。Nat Commun. (2025) 16:5653. doi: 10.1038/s41467-025-60806-1

2025-07-010
OAAI
Brain age mediates gut microbiome dysbiosis-related cognition in older adults
2025-02-270
OAAI
Impact of the polygenic risk scores for attention-deficit/hyperactivity disorder in Alzheimer's disease

注意缺陷多动障碍多基因风险评分对阿尔茨海默病的影响

2025-02-250
OAAI
Head‐to‐head comparison of four different plasma p‐tau217 assays to detect brain amyloid pathology and cognitive decline in diverse population‐based cohorts

四种不同血浆p-tau217检测方法的头对头比较:在基于人群的不同队列中检测脑淀粉样蛋白病理和认知下降

2025-01-090
OA
Exploring the utility of Plasma GFAP as a secondary endpoint in Alzheimer's disease Clinical trials to monitor disease progression

探索血浆GFAP作为阿尔茨海默病临床试验中监测疾病进展的次要终点指标的应用价值

2025-01-090
OA